-+ 0.00%
-+ 0.00%
-+ 0.00%

Lunai Bioworks regains Nasdaq $1 minimum bid price compliance, enters one-year monitoring period

PUBT·06/16/2026 20:01:41
Listen to the news
Lunai Bioworks regains Nasdaq $1 minimum bid price compliance, enters one-year monitoring period
  • Lunai Bioworks regained compliance with Nasdaq’s $1 minimum bid price rule, clearing a key listing risk flagged in prior panel extensions.
  • Nasdaq imposed a mandatory one-year panel monitor starting June 11, 2026.
  • A fresh bid-price breach during monitoring would trigger an immediate delisting determination, with no compliance plan or added cure period available.
  • The company would still be able to request a new Nasdaq Hearings Panel hearing, which would stay any suspension or delisting pending the outcome.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001731122-26-000865), on June 16, 2026, and is solely responsible for the information contained therein.